Zhongzhu Medical Holdings Co Ltd - Asset Resilience Ratio
Zhongzhu Medical Holdings Co Ltd (600568) has an Asset Resilience Ratio of 2.95% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 600568 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2001–2023)
This chart shows how Zhongzhu Medical Holdings Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Zhongzhu Medical Holdings Co Ltd.
Liquid Assets Composition Over Time
This chart breaks down Zhongzhu Medical Holdings Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 600568 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥80.00 Million | 2.95% |
| Total Liquid Assets | CN¥80.00 Million | 2.95% |
Asset Resilience Insights
- Limited Liquidity: Zhongzhu Medical Holdings Co Ltd maintains only 2.95% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhongzhu Medical Holdings Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhongzhu Medical Holdings Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM |
Drug Manufacturers - Specialty & Generic | 2.79% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 2.51% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Harbin Pharmaceutical Group Co Ltd
SHG:600664 |
Drug Manufacturers - Specialty & Generic | 0.97% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Annual Asset Resilience Ratio for Zhongzhu Medical Holdings Co Ltd (2001–2023)
The table below shows the annual Asset Resilience Ratio data for Zhongzhu Medical Holdings Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 7.62% | CN¥230.00 Million ≈ $33.66 Million |
CN¥3.02 Billion ≈ $441.75 Million |
+6.68pp |
| 2022-12-31 | 0.94% | CN¥35.00 Million ≈ $5.12 Million |
CN¥3.71 Billion ≈ $543.28 Million |
-1.66pp |
| 2021-12-31 | 2.61% | CN¥116.24 Million ≈ $17.01 Million |
CN¥4.46 Billion ≈ $652.33 Million |
+2.52pp |
| 2018-12-31 | 0.09% | CN¥5.00 Million ≈ $731.66K |
CN¥5.62 Billion ≈ $822.28 Million |
-1.77pp |
| 2017-12-31 | 1.86% | CN¥135.38 Million ≈ $19.81 Million |
CN¥7.27 Billion ≈ $1.06 Billion |
-0.94pp |
| 2016-12-31 | 2.80% | CN¥200.00 Million ≈ $29.27 Million |
CN¥7.14 Billion ≈ $1.04 Billion |
+1.64pp |
| 2015-12-31 | 1.16% | CN¥50.00 Million ≈ $7.32 Million |
CN¥4.29 Billion ≈ $628.05 Million |
+1.15pp |
| 2013-12-31 | 0.02% | CN¥490.38K ≈ $71.76K |
CN¥2.64 Billion ≈ $386.45 Million |
-0.02pp |
| 2012-12-31 | 0.04% | CN¥961.54K ≈ $140.70K |
CN¥2.25 Billion ≈ $329.78 Million |
+0.02pp |
| 2011-12-31 | 0.02% | CN¥458.93K ≈ $67.16K |
CN¥2.10 Billion ≈ $306.67 Million |
-0.03pp |
| 2010-12-31 | 0.05% | CN¥998.00K ≈ $146.04K |
CN¥2.12 Billion ≈ $310.88 Million |
+0.04pp |
| 2005-12-31 | 0.01% | CN¥100.12K ≈ $14.65K |
CN¥1.38 Billion ≈ $202.35 Million |
-0.03pp |
| 2004-12-31 | 0.04% | CN¥300.00K ≈ $43.90K |
CN¥771.64 Million ≈ $112.91 Million |
-0.01pp |
| 2003-12-31 | 0.05% | CN¥300.00K ≈ $43.90K |
CN¥569.42 Million ≈ $83.32 Million |
+0.01pp |
| 2002-12-31 | 0.04% | CN¥200.00K ≈ $29.27K |
CN¥478.20 Million ≈ $69.98 Million |
-43.88pp |
| 2001-12-31 | 43.92% | CN¥202.18 Million ≈ $29.58 Million |
CN¥460.31 Million ≈ $67.36 Million |
-- |
About Zhongzhu Medical Holdings Co Ltd
Zhongzhu Healthcare Holding Co.,Ltd engages in the research and development, production, and sale of drugs in China. The company offers Ophthalmic drugs, including pearl brightening eye drops, clindamycin phosphate for injection, acyclovir dispersible tablets, sodium cromoglycate eye drops, acyclovir for injection, diclofenac sodium suppositories, diclofenac sodium liniment, azithromycin granules… Read more